miR-545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG-I

被引：49

作者：

Song, Bin ^{[1
]}

Ji, Weiping ^{[1
]}

Gu, Shiwei ^{[1
]}

Liu, Anan ^{[1
]}

Jing, Wei ^{[1
]}

Shao, Chenghao ^{[1
]}

Li, Gang ^{[1
]}

Jin, Gang ^{[1
]}

机构：

[1] Second Mil Med Univ, Dept Pancreat Surg, Changhai Hosp, Shanghai 200082, Peoples R China

来源：

FEBS LETTERS | 2014年 / 588卷 / 23期

基金：

上海市自然科学基金;

关键词：

miR-545; Pancreatic ductal adenocarcinoma; RIG-I; Patients survival; Cancer growth; HEPATOCELLULAR-CARCINOMA; MICRORNAS; CANCER; RECOGNITION; SURVIVAL; RNA; ACTIVATION; APOPTOSIS; GENES; CELLS;

D O I：

10.1016/j.febslet.2014.10.004

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Pancreatic ductal adenocarcinoma (PDAC) ranks fourth on the list of cancer-related causes of death. Deregulation or dysfunction of miRNAs contribute to cancer development. In this study, we found that low miR-545 level and high RIG-I protein in PDAC tissues were both correlated with low survival rate. MiR-545 up-regulation inhibited PDAC cell lines growth and vice versa. 3'UTR of RIG-I was targeted by miR-545. Thus we concluded that low miR-545 levels in PDAC promote tumor cells growth, and this is associated with reduced survival in PDAC patients. MiR-545 exerts its effects by directly targeting RIG-1. (C) 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

引用

页码：4375 / 4381

页数：7

共 50 条

[1] Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma
Liu, Zhikui
Dou, Changwei
Yao, Bowen
Xu, Meng
Ding, Linglong
Wang, Yufeng
Jia, Yuli
Li, Qing
Zhang, Hongyong
Tu, Kangsheng
Song, Tao
Liu, Qingguang
ONCOTARGET, 2016, 7 (18) : 25350 - 25365
[2] MiR-940 Inhibited Pancreatic Ductal Adenocarcinoma Growth by Targeting MyD88
Song, Bin
Zhang, Chaoxiong
Li, Gang
Jin, Gang
Liu, Cong
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 35 (03) : 1167 - 1177
[3] Targeting mTOR in Pancreatic Ductal Adenocarcinoma
Iriana, Sentia
Ahmed, Shahzad
Gong, Jun
Annamalai, Alagappan Anand
Tuli, Richard
Hendifar, Andrew Eugene
FRONTIERS IN ONCOLOGY, 2016, 6
[4] Targeting Neoantigens in Pancreatic Ductal Adenocarcinoma
Singh, Gurkaranjot
Kutcher, Drew
Lally, Rajeshwar
Rai, Vikrant
CANCERS, 2024, 16 (11)
[5] Targeting Pancreatic Ductal Adenocarcinoma (PDAC)
Parrasia, Sofia
Zoratti, Mario
Szabo, Ildiko
Biasutto, Lucia
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2021, 55 (01) : 61 - 90
[6] Targeting RIG-I or STING promotes epithelial regeneration
Fischer, Julius C.
Poeck, Hendrik
ONCOTARGET, 2017, 8 (70) : 114418 - 114419
[7] RNF135 is a positive regulator of IFN expression and involved in RIG-I signaling pathway by targeting RIG-I
Lai, Yuxiong
Liang, Min
Hu, La
Zeng, Zicheng
Lin, Hai
Yi, Gao
Li, Ming
Liu, Zhaoyu
FISH & SHELLFISH IMMUNOLOGY, 2019, 86 : 474 - 479
[8] miR-26a suppresses the growth and metastasis via targeting matrix metalloproteinase 14 in pancreatic ductal adenocarcinoma
Zhong, Yuchuan
Yao, Guowang
Zhao, Guang
Zhang, Dapeng
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (04): : 4803 - 4809
[9] RNF122 suppresses antiviral type I interferon production by targeting RIG-I CARDs to mediate RIG-I degradation
Wang, Wendie
Jiang, Minghong
Liu, Shuo
Zhang, Shikun
Liu, Wei
Ma, Yuanwu
Zhang, Lianfeng
Zhang, Jiyan
Cao, Xuetao
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (34) : 9581 - 9586
[10] RNF122 suppresses antiviral type I interferon production by targeting RIG-I CARD to mediate RIG-I degradation
Jiang, M.
Wang, W.
Liu, S.
Zhang, S.
Liu, W.
Ma, Y.
Zhang, L.
Zhang, J.
Cao, X.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 690 - 691

← 1 2 3 4 5 →